The analgesic effect of intraarticular OnabotulinumtoxinA in a female murine model of collagenase induced chronic degenerative monoarthritis

被引:6
作者
Blanshan, Nicole [1 ]
Mahowald, Maren L. [1 ,2 ]
Dorman, Christopher [1 ]
Frizelle, Sandra [1 ]
Krug, Hollis E. [1 ,2 ]
机构
[1] Vet Affairs Med Ctr, Rheumatol Dept, Minneapolis, MN USA
[2] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA
关键词
Botox (TM); Osteoarthritis; Mouse; Pain; Neurotoxins; BOTULINUM-TOXIN-A; ARTHROSCOPIC SURGERY; RHEUMATIC CONDITIONS; CONTROLLED-TRIAL; PAIN; OSTEOARTHRITIS; ARTHRITIS; PREVALENCE; NEUROTOXINS; MECHANISM;
D O I
10.1016/j.toxicon.2018.11.307
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: We previously reported the efficacy of intraarticular (IA) rimabotulinumtoxinB (BoNT/B) in a murine model of chronic degenerative arthritis pain. This study aimed to measure the analgesic effects of onabotulinumtoxinA (BoNT/A) on collagenase induced chronic degenerative arthritis joint pain. Methods: Chronic degenerative arthritis was produced by IA injection of 10 I collagenase (Col) (10 IU) into the left knee of C57BL/6J female mice 4 weeks prior to pain assessment. IA BoNT/A was injected 3 days before testing. Arthritis pain was measured as evoked pain scores (EPS) and spontaneous pain behaviors with an advanced dynamic weight bearing (ADWB) device. EPS was a tally of fights and vocalizations exhibited in one minute with knee palpation. Percent body weight and percent time spent on each limb was quantified. All mice were 12 weeks old at the time of examination. Results: IA Col increased EPS and reduced ADWB measures of percent weight bearing on the left hind limb compared to naive mice. BoNT/A treatment reduced EPS and increased weight bearing on the left hind limb. The improvements were not significant compared to the Col group. There was no significant difference in time spent on the left hind limb between any treatment groups. Forelimb ADWB measures of percent weight and time in arthritic mice significantly increased compared to nonarthritic animals. Treatment with BoNT/A in the arthritic limb decreased this offloading; however, statistical analysis only showed significance in weightbearing. Conclusion: IA Col monoarthritis increased evoked and spontaneous pain behaviors in female mice after four weeks. Treatment with IA BoNT/A decreased pain behaviors but only forelimb weight bearing showed a significant improvement. This led us to conclude that treatment with BoNT/A is not an effective analgesic for the treatment of chronic degenerative knee arthritis in murine models.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 50 条
[1]   The effect of intra-articular vanilloid receptor agonists on pain behavior measures in a murine model of acute monoarthritis [J].
Abdullah, Mishal ;
Mahowald, Maren L. ;
Frizelle, Sandra P. ;
Dorman, Christopher W. ;
Funkenbusch, Sonia C. ;
Krug, Hollis E. .
JOURNAL OF PAIN RESEARCH, 2016, 9 :563-570
[2]  
Anderson Stephanie, 2010, J Pain Res, V3, P161, DOI 10.2147/JPR.S12520
[3]  
[Anonymous], Guide for the care and use of laboratory animals
[4]   Future aspects of botulinum neurotoxins [J].
Aoki, K. R. .
JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (04) :567-573
[5]   Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A [J].
Aoki, KR .
NEUROTOXICOLOGY, 2005, 26 (05) :785-793
[6]   Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions [J].
Aoki, KR ;
Guyer, B .
EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 :21-29
[7]   Structure of dual receptor binding to botulinum neurotoxin B [J].
Berntsson, Ronnie P-A ;
Peng, Lisheng ;
Dong, Min ;
Stenmark, Pal .
NATURE COMMUNICATIONS, 2013, 4
[8]  
Bert Joseph, 2016, Intern Med Rev (Wash D C), V2016
[9]   Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains [J].
Burstein, Rami ;
Zhang, XiChun ;
Levy, Dan ;
Aoki, K. Roger ;
Brin, Mitchell F. .
CEPHALALGIA, 2014, 34 (11) :853-869
[10]  
Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1261